Clinical Trial Update: Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating regorafenib in combination with multimodal metronomic chemotherapy for chemo-resistant metastatic colorectal cancer. Recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING